PRA Health Sciences, Inc. (NASDAQ:PRAH) will be hosting a conference call at 9:00 AM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community.
The company disclosed financial results after close of U.S. markets on Wednesday 4th November 2020
A live webcast with presentations will be available on the Internet by visiting the Company website prahs.com
Earnings Expectation
PRA Health Sciences, Inc. is reporting third quarter financial results on Wednesday 4th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, PRAH is expected to report 3Q20 income of $ 1.12 per share from revenue of $ 764.98 million.
For the full year, analysts anticipate top line of $ 3094.68 million, while looking forward to income of $ 4.43 per share bottom line.
The Company Outlook
Earnings for 3Q20 are anticipated in a range of $ 1.09 ~ $ 1.19 per share, while revenues are expected in a range of $ 754.00 million ~ $ 784.00 million
Full Year 2020 topline are forecasted in a range of$ 3,070.00 million ~ $ 3,130.00 million, where as bottomline are predicted in a range of $ 4.35 ~ $ 4.55 per share
Click Here For More Historical Outlooks Of PRA Health Sciences, Inc.
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.
